(Reuters) -Biogen said on Wednesday it had agreed to buy privately held Human Immunology Biosciences for up to $1.8 billion, gaining access to targeted therapies
Day: May 22, 2024
Off-price retailer TJX posts upbeat Q1, lifts annual profit view on robust demand
By Anuja Bharat Mistry (Reuters) -TJ Maxx parent TJX Cos posted better-than-expected first-quarter results and raised its annual profit forecast on easing costs and strong
Target issues weak forecast as shoppers pull back; shares tumble
By Siddharth Cavale and Ananya Mariam Rajesh (Reuters) -Target on Wednesday said it expects consumer caution to persist after it reported quarterly earnings that missed
Goldman Sachs CEO says Fed unlikely to cut rates this year
By Suzanne McGee BOSTON (Reuters) – Goldman Sachs CEO David Solomon said on Wednesday he does not expect the Federal Reserve to cut interest rates